Shearman & Sterling advised Crescent Capital on a unitranche refinancing of 3B Scientific Group, a leading global manufacturer of anatomical and biological teaching aids for science, healthcare and patient education.
The group was acquired by Whitney Capital Partners at the beginning of 2017.
3B Scientific was founded in 1948 in Hamburg, Germany and has grown to be the world’s leading manufacturer of anatomical and biological teaching aids for science, healthcare and patient education. Represented in over 100 countries worldwide, the brand name 3B Scientific® stands for best quality, best value and best service.
Crescent Capital Group LP is headquartered in Los Angeles with offices in Boston, London and New York. With more than 80 investment professionals and approximately 150 employees, the firm invests at all levels of the capital structure, with a significant focus on below investment grade credit through strategies that invest in senior bank loans, high yield debt, mezzanine debt, distressed debt and other private debt securities.
The Shearman & Sterling team included partner Winfried M. Carli (Picture) (Frankfurt-Finance); of counsel Steven Sherman (New York-Finance); counsel Matthias Weissinger (Frankfurt-Finance) and Nathan Tasso (Washington, DC-Tax); and associate Addison Pierce (London-Finance).
Involved fees earner: Winfried Carli – Shearman & Sterling; Steven Sherman – Shearman & Sterling; Matthias Weissinger – Shearman & Sterling; Addison Pierce – Shearman & Sterling; Nathan Tasso – Shearman & Sterling;
Law Firms: Shearman & Sterling;
Clients: Crescent Capital;